Chardan Capital Markets
Overview
Chardan Capital Markets is an independent, full-service, global investment bank focused on supporting the capital markets goals of corporate and institutional clients. The firm has broad deal experience, having participated in more than 700 transactions with an aggregate transaction value of over $120 billion. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of FINRA, SIPC, and NASDAQ. The firm specializes in enabling healthcare and disruptive technologies, seeking enduring opportunities that change lives and drive society forward. Chardan's unique research enables it to successfully uncover emergent growth areas, providing a direct and intellectually honest point of view. Chardan has established a leading SPAC practice, with an 18-year history, 116 SPACs underwritten, led, or co-managed, including 14 self or co-sponsored SPACs. Additionally, since 2018, Chardan has acted as M&A advisor in 29 SPAC merger transactions. The firm's commitment to creative solutions for companies seeking access to capital is further demonstrated by the launch of ChEF (Chardan Equity Facility), a program designed to provide flexible capital solutions to emerging growth companies. Chardan's leadership team includes Steven Urbach as Co-Founder and CEO, Jonas Grossman as President, and Kerry Propper as Co-Founder and Executive Chairman. The firm's culture emphasizes innovation, entrepreneurship, and forward-thinking, fostering a driven and collegial environment. Chardan's services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access, and institutional trading. The firm's focus on healthcare and disruptive technologies positions it as a key player in bringing innovative solutions to the market, with a commitment to moving society forward through its investments and advisory services.
Investment Focus
- Strong growth potential
- Innovative business models
- Experienced management teams
- Scalable operations
- Clear path to profitability
- Alignment with Chardan's focus areas in healthcare and disruptive technologies
Portfolio Companies
Get the full list of 54,000+ investors
Chardan Capital Markets and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Chardan Capital Markets
What sectors does Chardan Capital Markets invest in?
Chardan Capital Markets invests in Financial Services, Technology, Healthcare, FinTech, Artificial Intelligence and Blockchain, and is based in New York, United States. Chardan Capital Markets is listed as a investment bank in the ConnectSafely investor database.
What stage does Chardan Capital Markets invest at?
Chardan Capital Markets backs companies at Early Stage, Growth, Late Stage, Pre-IPO, Buyout and Turnaround, writing cheques of 1M - 50M.
Which regions does Chardan Capital Markets invest in?
Chardan Capital Markets invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Chardan Capital Markets invested in?
Chardan Capital Markets's portfolio includes Krystal Biotech, Immuneering Corporation and Biocept.
How do I contact Chardan Capital Markets?
Chardan Capital Markets's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
